Literature DB >> 23842074

Missed opportunities among HIV-positive women to control viral replication during pregnancy and to have a vaginal delivery.

Karoline Aebi-Popp1, Fiona Mulcahy, Tracy R Glass, Christoph Rudin, Begona Martinez de Tejada, Barbara Bertisch, Jan Fehr, Claudia Grawe, Kathrin Scheibner, Martin Rickenbach, Irene Hoesli, Claire Thorne.   

Abstract

INTRODUCTION: Most national guidelines for the prevention of mother-to-child transmission of HIV in Europe updated between 2001 and 2010 recommend vaginal deliveries for women with undetectable or very low viral load (VL). Our aim was to explore the impact of these new guidelines on the rates of vaginal deliveries among HIV-positive women in Europe.
METHODS: In a pooled analysis of data on HIV-positive pregnant women enrolled in the Swiss Mother & Child HIV Cohort Study and the European Collaborative Study 2000 to 2010, deliveries were classified as occurring pre- or postpublication of national guidelines recommending vaginal delivery.
RESULTS: Overall, 2663 women with 3013 deliveries were included from 10 countries; 28% women were diagnosed with HIV during pregnancy. Combination antiretroviral therapy was used in most pregnancies (2020, 73%), starting during the first or second trimester in 78% and during the third trimester in 22%; in 25% pregnancies, the woman conceived on combination antiretroviral therapy. Overall, in 86% pregnancies, a VL < 400 copies per milliliter was achieved before delivery. The proportion of vaginal deliveries increased from 17% (414/2377) before the change in guidelines to 52% (313/600) after; elective Caesarean section rates decreased from 65% to 27%. The proportion of women with undetectable VL having a Caesarean section was 55% after implementation of new guidelines. We observed a decrease of late preterm deliveries from 16% (377/2354) before to 7% (42/599) after the change in guidelines (P < 0.001).
CONCLUSION: There are still missed opportunities for women with HIV to fully suppress their VL and to deliver vaginally in Europe.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23842074     DOI: 10.1097/QAI.0b013e3182a334e3

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  9 in total

1.  Full Viral Suppression, Low-Level Viremia, and Quantifiable Plasma HIV-RNA at the End of Pregnancy in HIV-Infected Women on Antiretroviral Treatment.

Authors:  Silvia Baroncelli; Maria F Pirillo; Enrica Tamburrini; Giovanni Guaraldi; Carmela Pinnetti; Anna Degli Antoni; Clementina M Galluzzo; Chiara Stentarelli; Roberta Amici; Marco Floridia
Journal:  AIDS Res Hum Retroviruses       Date:  2015-04-08       Impact factor: 2.205

2.  Changing Patterns and Factors Associated With Mode of Delivery Among Pregnant Women With Human Immunodeficiency Virus Infection in the United States.

Authors:  Kartik K Venkatesh; Leavitt Morrison; Elizabeth G Livingston; Alice Stek; Jennifer S Read; David E Shapiro; Ruth E Tuomala
Journal:  Obstet Gynecol       Date:  2018-05       Impact factor: 7.661

3.  Pregnancy and neonatal outcomes among a cohort of HIV-infected women in a large Italian teaching hospital: a 30-year retrospective study.

Authors:  S Grignolo; R Agnello; D Gerbaldo; C Gotta; C Alicino; F Del Puente; L Taramasso; B Bruzzone; C Gustavino; S Trasino; A DE Maria; G Icardi; C Viscoli; A DI Biagio
Journal:  Epidemiol Infect       Date:  2017-03-22       Impact factor: 4.434

4.  Most women living with HIV can deliver vaginally-National data from Finland 1993-2013.

Authors:  Inka Aho; Marja Kaijomaa; Pia Kivelä; Heljä-Marja Surcel; Jussi Sutinen; Oskari Heikinheimo
Journal:  PLoS One       Date:  2018-03-22       Impact factor: 3.240

5.  High prevalence of herpes simplex virus (HSV)- type 2 co-infection among HIV-positive women in Ukraine, but no increased HIV mother-to-child transmission risk.

Authors:  Karoline Aebi-Popp; Heather Bailey; Ruslan Malyuta; Alla Volokha; Claire Thorne
Journal:  BMC Pregnancy Childbirth       Date:  2016-04-27       Impact factor: 3.007

6.  Mode of Delivery among HIV-Infected Pregnant Women in Philadelphia, 2005-2013.

Authors:  Dana R Thompson; Florence M Momplaisir; Joëlla W Adams; Baligh R Yehia; Emily A Anderson; Gregg Alleyne; Kathleen A Brady
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

7.  Maternal and foetal outcomes among 4118 women with HIV infection treated with lopinavir/ritonavir during pregnancy: analysis of population-based surveillance data from the national study of HIV in pregnancy and childhood in the United Kingdom and Ireland.

Authors:  Pat A Tookey; Claire Thorne; Jean van Wyk; Michael Norton
Journal:  BMC Infect Dis       Date:  2016-02-04       Impact factor: 3.090

8.  Patterns of caesarean section in HIV infected and non-infected women in Malawi: is caesarean section used for PMTCT?

Authors:  Lyson Tenthani; Joep J van Oosterhout; Andreas D Haas; Malango Msukwa; Nozgechi Phiri; Frank Chimbwandira; Kali Tal; Karoline Aebi-Popp; Janne Estill; Olivia Keiser
Journal:  BMC Pregnancy Childbirth       Date:  2018-04-12       Impact factor: 3.007

9.  Evolving treatment implementation among HIV-infected pregnant women and their partners: results from a national surveillance study in Italy, 2001-2015.

Authors:  Marco Floridia; Valentina Frisina; Marina Ravizza; Anna Maria Marconi; Carmela Pinnetti; Irene Cetin; Matilde Sansone; Atim Molinari; Francesca Cervi; Alessandra Meloni; Kety Luzi; Giulia Masuelli; Enrica Tamburrini
Journal:  J Glob Health       Date:  2017-06       Impact factor: 4.413

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.